**Core Concept**
Hypercalcemia is a condition characterized by elevated serum calcium levels, which can lead to various symptoms such as confusion, shortness of breath, and obtundation. In this patient, the presence of normal PTH and elevated PTHrP suggests a possible paraneoplastic syndrome associated with malignancy.

**Why the Correct Answer is Right**
The correct answer is a medication that should not be used to treat hypercalcemia. In this scenario, the patient has elevated PTHrP, which suggests a paraneoplastic syndrome. The treatment for hypercalcemia in such cases involves addressing the underlying malignancy and using medications that help reduce calcium levels. The correct answer is a medication that can worsen hypercalcemia or has limited efficacy in treating it.

**Why Each Wrong Option is Incorrect**
* **Option A:** Furosemide is a loop diuretic that can be used to treat hypercalcemia by increasing urinary calcium excretion. It is a common medication used in the management of hypercalcemia.
* **Option B:** Bisphosphonates, such as pamidronate, are effective in reducing bone turnover and can be used to treat hypercalcemia. They work by inhibiting osteoclast-mediated bone resorption.
* **Option C:** Calcitonin is a hormone that can be used to treat hypercalcemia by reducing bone resorption and increasing renal calcium excretion. It is often used in the acute management of hypercalcemia.

**Clinical Pearl / High-Yield Fact**
In the management of hypercalcemia, it is essential to consider the underlying cause, as this will guide the choice of treatment. For example, in cases of paraneoplastic syndrome associated with malignancy, addressing the underlying cancer is crucial, whereas in cases of primary hyperparathyroidism, surgical intervention may be necessary.

**Correct Answer:** D.